Acknowledgement
This study was supported by research grant from the Seoul National University Bundang Hospital (grant No. 06-2023-0034).
References
- Mujtaba SS, Ledingham S, Shah AR, Schueler S, Clark S, Pillay T. Thrombocytopenia after aortic valve replacement: comparison between sutureless Perceval S valve and Perimount Magna Ease bioprosthesis. Braz J Cardiovasc Surg 2018;33:169-75. https://doi.org/10.21470/1678-9741-2017-0157
- Weerasinghe A, Taylor KM. The platelet in cardiopulmonary bypass. Ann Thorac Surg 1998;66:2145-52. https://doi.org/10.1016/s0003-4975(98)00749-8
- Griffin BR, Bronsert M, Reece TB, et al. Thrombocytopenia after cardiopulmonary bypass is associated with increased morbidity and mortality. Ann Thorac Surg 2020;110:50-7. https://doi.org/10.1016/j.athoracsur.2019.10.039
- Phan K, Tsai YC, Niranjan N, et al. Sutureless aortic valve replacement: a systematic review and meta-analysis. Ann Cardiothorac Surg 2015;4:100-11. https://doi.org/10.3978/j.issn.2225-319x.2014.06.01
- Laufer G, Haverich A, Andreas M, et al. Long-term outcomes of a rapid deployment aortic valve: data up to 5 years. Eur J Cardiothorac Surg 2017;52:281-7. https://doi.org/10.1093/ejcts/ezx103
- Konig KC, Wahlers T, Scherner M, Wippermann J. Sutureless Perceval aortic valve in comparison with the stented Carpentier-Edwards Perimount aortic valve. J Heart Valve Dis 2014;23:253-8.
- Sanchez E, Corrales JA, Fantidis P, et al. Thrombocytopenia after aortic valve replacement with Perceval S sutureless bioprosthesis. J Heart Valve Dis 2016;25:75-81.
- Stegmeier P, Schlomicher M, Stiegler H, Strauch JT, Bechtel JF. Thrombocytopenia after implantation of the Perceval S aortic bioprosthesis. J Thorac Cardiovasc Surg 2020;160:61-8. https://doi. org/10.1016/j.jtcvs.2019.07.046
- Lorusso R, Jiritano F, Roselli E, et al. Perioperative platelet reduction after sutureless or stented valve implantation: results from the PERSIST-AVR controlled randomized trial. Eur J Cardiothorac Surg 2021;60:1359-65. https://doi.org/10.1093/ejcts/ezab175
- Mitrosz M, Chlabicz M, Hapaniuk K, et al. Thrombocytopenia associated with TAVI: the summary of possible causes. Adv Med Sci 2017;62:378-82. https://doi.org/10.1016/j.advms.2017.04.003
- Jiritano F, Santarpino G, Serraino GF, et al. Peri-procedural thrombocytopenia after aortic bioprosthesis implant: a systematic review and meta-analysis comparison among conventional, stentless, rapid-deployment, and transcatheter valves. Int J Cardiol 2019;296:43-50. https://doi.org/10.1016/j.ijcard.2019.07.056
- Mitrosz M, Kazimierczyk R, Sobkowicz B, et al. The causes of thrombocytopenia after transcatheter aortic valve implantation. Thromb Res 2017;156:39-44. https://doi.org/10.1016/j.thromres.2017.05.020
- Dvir D, Genereux P, Barbash IM, et al. Acquired thrombocytopenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes. Eur Heart J 2014;35:2663-71. https://doi.org/10.1093/eurheartj/ehu082
- Jiritano F, Cristodoro L, Malta E, Mastroroberto P. Thrombocytopenia after sutureless aortic valve implantation: comparison between Intuity and Perceval bioprostheses. J Thorac Cardiovasc Surg 2016;152:1631-3. https://doi.org/10.1016/j.jtcvs.2016.07.054
- Rotman OM, Bianchi M, Ghosh RP, Kovarovic B, Bluestein D. Principles of TAVR valve design, modelling, and testing. Expert Rev Med Devices 2018;15:771-91. https://doi.org/10.1080/17434440.2018.1536427
- Velho TR, Pereira RM, Fernandes F, Guerra NC, Ferreira R, Nobre A. Bioprosthetic aortic valve degeneration: a review from a basic science perspective. Braz J Cardiovasc Surg 2022;37:239-50. https://doi.org/10.21470/1678-9741-2020-0635
- Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 2009;119: 1034-48. https://doi.org/10.1161/circulationaha.108.778886